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Introduction 
Stroke is the third leading cause of death and long-term 
disability in the industrial countries and even if they 
survive, the patients may be permanently disabled in 
memorizing, talking and walking. Strokes are induced 
by hemorrhage and ischemia, about 15% and 85%, 
respectively, and also ischemia itself is occurred by 
different factors such as thrombosis, embolism, and 
systemic perfusion (White et al., 2000). Ischemia causes 
neurological injury and subsequently the recirculation 
of blood to the injured tissues leads to reperfusion. 
During reperfusion, oxygen free radicals and other 
oxidative agents lead to higher cell damages than 
ischemia does. In addition, upon blood recirculation to 
the injured tissue, lack of oxygen and nutrients induce 
inflammation and oxidative damages, instead of 
sustaining normal activity. After establishment of 
cerebral blood flow, the returned blood flow and 
occlusion contribute to diffusion of oxygen into the 
cells, resulting necrosis and apoptosis (Lo et al., 2003). 
Ischemia decreases oxygen and nutrients levels trans-
ported to the nervous system and consequently 
corrupts their function  In addition, oxygen deficiency 
contributes to decrease of ATP production in cells and 
consequently the cells switch to anerobic respiration 
pathway to achieve their needed energy, leading 
accumulation of lactate and cell death (Lo et al., 2003). 
Now-a-days, medical plants possess a high state in the 
therapeutic protocols of many countries. Accordingly, 
many studies have been focused on anti-oxidants, as 
neuroprotective agents, to treat strokes. Early diagnosis 
and medical intervention could ameliorate the effects of 
ischemia as well as reduce cell death through inhibiting 
of apoptosis. 
Anti-oxidants are substances preventing cell death 
through scavenging free radicals and eliminating the 
hazardous compounds generated during cell damage, 
thereby protecting healthy cells, especially their 
membrane and nucleus. Therefore, it is necessary to 
investigate the potential therapeutic effects of anti-
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Abstract
The aim of study was to investigate the potential neuroprotective effects of 
Kombucha on cerebral damage induced by ischemia in rats (n=99). Cerebral 
infarct volume in the ischemic rats received Kombucha solution showed no 
significance alteration. However, the permeability of blood-brain barrier 
significantly decreased in both ischemic rats received 15 mg/kg Kombucha 
tea and Sham group. In addition, brain water content in the ischemic groups 
treated with Kombucha solution was significantly higher than the Sham 
group, although right hemispheres in all of the treated groups illustrated 
higher brain water content than the left ones. Brain anti-oxidant capacity 
elevated in the ischemic rats treated with Kombucha and in the Sham group. 
Brain and plasma malondialdehyde concentrations significantly decreased in 
both of the ischemic groups injected with Kombucha. The findings suggest 
that Kombucha tea could be useful for the prevention of cerebral damage. 
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 oxidants, more especially those originated from plants, 
on brain damages after stroke.   
Kombucha tea drink is a functional fermented beverage 
produced through fermenting the tea using a symbiotic 
colony of bacteria and yeast. Due to its anti-oxidant 
properties, Kombucha tea is one of the plants likely 
possess protective effects against ischemia (Greenwalt 
et al., 1998; Malbaša et al., 2011; Ibrahim et al., 2013). 
Hence, the present study was aimed to evaluate the 
potential neuroprotective effects of Kombucha tea on 
the water content and hemostasis of Wistar rat brain.  
 
Materials and Methods 
Preparation of Kombucha solution 
The tea (10 g) and sugar (80 g) were added into a one-
liter sterile conical flask containing boiling water. Then, 
the solution was poured into some dishes and the 
fungus was cultured and incubated at 28 ± 1°C for 8-10 
days. The surface of the dishes was covered with a 
piece of fabric and kept in a clean and dark room 
(Kastner and Freund, 1991). 
Animal and treatments 
Ninety-eight male Wistar rats (250-300 g) were kept 
under a controlled condition (22 ± 2°C  ,21 L: 12D light 
cycle, and sufficient food).  
The animals were separated into seven experimental 
groups (n = 14 for each group): Control group: No 
surgery and Kombucha administration, but received 
distilled water; Sham group: No Kombucha administra-
tion, but underwent surgery without blocking the 
carotid arteries; Ischemic group 1: No Kombucha 
administration; Ischemic group 2: Intraperitoneally 
injected with 5 mg/kg Kombucha solution; Ischemic 
group 3: Intraperitoneally injected with 15 mg/kg 
Kombucha solution; Kombucha treated group 1: Only 
intraperitoneally received 5 mg/kg Kombucha solution; 
Kombucha treated group 2: Only intraperitoneally 
received 15 mg/kg Kombucha solution. 
Ischemia induction (Video Clip) 
The rats were anesthetized by intraperitoneally inject-
tion of ketamin and xylazine (50 and 5 mg per kg, 
respectively). Middle cerebral artery occlusion was 
performed as described elsewhere (Long et al., 1989). 
Briefly, using microscopic surgery, a 3-0 nylon suture 
was introduced through the external carotid artery 
stump and advanced into the internal carotid until mild 
resistance where the tip was lodged in the anterior 
cerebral artery and blocked the blood flow to the 
middle cerebral artery. Finally, after an hour-ischemic 
period, reperfusion was started by withdrawing the 
suture (Rabiei et al., 2012). 
Measurement of brain cerebral edema 
The brains of the ischemic groups and the other ones 
used for evaluation of cerebral edema were dissected 
and the pons, cerebellums and olfactory bulbs were 
isolated, and then the sound and ischemic hemispheres 
were separated and weighted. The weighted samples 
were dried in an Oven (110°C for 24 hours). Brain water 
content was calculated using the following equation (1), 
and the difference of brain water contents between the 
two hemispheres used as an indicator of edema severity 
(Rabiei et al., 2012). 
 
Ischemic hemisphere water content (IBWC), sound hemisphere 
water content (SBWC) 
Assessment of brain infarct volume  
After scarifying the animals with chloroform, they were 
decapitated and the brain rapidly excised and cooled 
within a saline solution at 4°C for 5 min. The samples 
were placed into a brain matrix and then coronally 
sectioned (2 mm). To stain the sections, they were 
immersed in 2% 2,3,5–triphenyl tetrazolium chloride 
solution at 37°C for 15 min. The stained sections were 
digitally photographed using a digital camera (Lumix; 
Panasonic, Japan) and their unstained areas were 
measured using image analysis software (UTHSCSA 
Image Tool) and defined as infarct area.  
Evaluation of blood-brain barrier permeability 
Integrity of blood-brain barrier was evaluated through 
measuring Evans blue dye removed from brain. Evans 
blue (2%; 4 mg/kg body weight) was injected 30 min 
after induction of ischemia. Then, after blood reperfu-
sion, the rats were deeply anesthetized and 250 mL of a 
warm normal saline (37°C was infused into their left 
ventricular catheters, thereby washing out the remnants 
of Evans blue from the circulation system. After 
decapitating, the brains were immediately removed to 
measure the weight of hemispheres. The hemispheres 
were separately homogenized in 2.5 mL phosphate 
buffered saline, and 2.5 mL of 60% trichloroacetic acid 
was added to precipitate their proteins. The mixture 
was stirred and centrifuged at 10,000 rpm for 30 min. 
Finally, Evans blue absorbance of the extracted super-
natant was measured at 610 nm by spectrometer, and 
the concentration of the tissue Evans blue content was 
calculated according to its standard curve.  
Determination of plasma anti-oxidant capacity   
To determine serum anti-oxidant capacity of the experi-
mental rats, their blood was collected to evaluate the 
biochemical parameter according to a common method. 
Briefly, a series of iron ion standard solutions was 
prepared and mixed with ferric reducing anti-oxidant 
power agent (FRAP), containing acetate buffer, 25 mL; 
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 2,4,6-tripyridl-s-triazine (TPTZ), 2-5 mL; and FeCl3, 2.5 
mL. For each of the experimental groups, the collected 
serum and FRAP were mixed and the total anti-oxidant 
capacity was determined based on ferrous form (µmol/
L) using spectrometer at 593 nm (Rabiei et al., 2012). 
Determination of brain anti-oxidant capacity 
Brain anti-oxidant capacity of the experimental rats was 
measured according to Schmidt-Kaster method (Rabiei  
et al., 2012). Briefly, the brains were carefully removed, 
homogenized and centrifuged at 10,000 rpm, and then 
50 µL of the supernatant was added to a freshly 
prepared TPTZ at 37°C. The mixture absorbance was 
measured by spectrometer at 593 nm. 
Determination of plasma malondialdehyde level 
P-MDA was determined in H3PO4-treated plasma after 
derivatization by thiobarbituric acid (TBA) and separa-
tion on HPLC. Briefly, 50 µL of the collected plasma 
was mixed in 50 µL of 0.05% BHT. Then, 400 µL of 0.44 
H3PO4 and 100 µL TBA (42 mM) were consecutively 
added to the mixture and heated (100°C for 60 min) and 
cooled (0°C for 5 min). The mixture was homogenized 
and centrifuged (14,000 rpm for 5 min) after adding 250 
µL of normal butanol, and finally, 20 µL of the 
supernatant was injected into HPLC (Block, 1999; 
Kamalakannan and Balakrishnan, 2015). 
Determination of brain malondialdehyde level 
To measure brain malondialdehyde level in brain, 1 mL 
of the collected tissues for each of the experimental 
groups was homogenized in 2.5% KCl (10% w/v) and 
incubated in a metabolic shaker (at 37 ± 1°C for 60 min). 
Thereafter, 1 mL of 5% trichloroacetic acid and 1 mL  of 
67% TBA reagent were added into the metabolic shaker. 
The final mixture was thoroughly homogenized again 
and centrifuged at 2,000 xg for 15 min; finally, after 
heating in a boiling water bath for 10 min, the obtained 
supernatant was cooled and its malondialdehyde level  
was measured at 535 nm by spectrometer (Rabiei et al., 
2012). 
Statistical analysis  
All data were analyzed using SPSS 16 and expressed as 
the mean ± standard deviation (SD). Multiple group 
comparisons of the means were carried out using a one 
way analysis of variance (ANOVA), and Dennett’s and 
Tukey tests were used to compare the differences 
between the experimental groups and the control group 
(p<0.05).    
 
Results 
Effects on cerebral edema  
Cerebral edema in the ischemic rats intraperitoneally 
received 5 and 15 mg/kg Kombucha solution showed 
no significance difference, despite a dose-dependent 
reduction, when compared to the ischemic group with 
no Kombucha injection (p>0.05; Figure 1).  
Blood-brain barrier permeability 
Permeability of the blood-brain barrier significantly 
decreased (p<0.05) in the ischemic group treated with 
higher concentration of Kombucha solution (15 mg/kg) 
and also in the Sham group when compared to the 
ischemic group with no Kombucha injection. Moreover, 
a comparison between the left and right hemispheres 
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Figure 1: Cerebral edema in the ischemic groups, intraperitoneally injected with of Kombucha solution:  And the ischemic group 
with no Kombucha treatment. Ischemia group 1, no Kombucha administration; ischemia group 2, intraperitoneally injected with 5 
mg/kg Kombucha solution; and ischemia group 3, intraperitoneally injected with 15 mg/kg Kombucha solution 
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 showed that permeability of the left ones unchanged in 
the ischemic groups treated with Kombucha solution as 
well as Sham group when compared to the ischemic 
group received no Kombucha solution (Figure 2).  
Effects on body water content  
Body water content of the ischemic group received 
higher concentration of Kombucha solution (15 mg/kg) 
increased significantly in compare to the Sham group 
(p<0.05). However, body water content in all of the 
ischemic groups was significantly higher than the Sham 
group, although right hemispheres in all of the groups 
illustrated higher body water content than the left ones 
(Figure 3).  
Plasma and brain anti-oxidant capacity  
Anti-oxidant capacity of plasma showed no significance 
difference between the rats intraperitoneally received 
Kombucha solution and the control group (Figure 4). By 
contrast, brain anti-oxidant capacity significantly 
increased in the ischemic group treated with 15 mg/kg 
Kombucha solution and also in the Sham group (p< 
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Figure 2: BBB permeability of the left and right hemispheres in the ischemic group1, received no Kombucha solution; ischemia 
group 2, intraperitoneally injected with 5 mg/kg Kombucha solution; ischemia group 3, intraperitoneally injected with 15 mg/kg 
Kombucha solution; and the Sham group, with no drug administration. Significance difference is denoted by asterisk (a). Data are 
expressed as mean ± SD 
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Figure 3: BWC of the right and left hemispheres of the ischemic group1, received no Kombucha solution; ischemia group 2, intra-
peritoneally injected with 5 mg/kg Kombucha solution; ischemia group 3, intraperitoneally injected with 15 mg/kg Kombucha 
solution; and the Sham group, with no drug administration. Data are expressed as mean ± SD  
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 0.05; Figure 5). 
Brain and plasma malondialdehyde level 
Mean concentration of malondialdehyde in brain and 
plasma of the ischemic groups (Figure 6 and 7, 
respectively) treated with Kombucha tea significantly 
decreased when compared to the control group 
(p<0.05).   
Brain histopathological changes in the Ischemic groups 
Coronal histopathological evaluation of cerebral infarct 
volume (unstained area) in the ischemic groups showed 
approximately a same level of unstained area, as an 
indicator of infarct volume, 24 hours after ischemia 
induction (Figure 8).   
 
Discussion 
The results showed that Kombucha tea injection 
reduces cerebral edema, infarct volume and 
permeability of brain barriers through increasing blood-
brain barrier integrity. Moreover, the concentrations of 
brain and plasma malondialdehyde significantly 
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Figure 4: Plasma anti-oxidant capacity in the ischemic rat groups, intraperitoneally injected with 5 and 15 mg/kg of Kombucha 
solution; the control group, received no Kombucha solution; and the Sham group, with no drug administration. Data are ex-
pressed as mean ± SD 
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Figure 5: Brain anti-oxidant capacity in the ischemic rat groups, intraperitoneally injected with 5 and 15 mg/kg of Kombucha solu-
tion; Control group, received no Kombucha solution; and the Sham group, with no drug administration. Significance difference is 
denoted by asterisk (a). Data are expressed as mean ± SD 
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 increased in the group received no Kombucha solution.  
During ischemia and reperfusion a series of cellular and 
molecular processes can result in damage to the 
nervous/non-nervous cells and brain capillaries. Of 
these events are cell cytotoxicity, oxidative stress, lipid 
peroxidation, inflammation and subsequently the 
breakdown of blood-brain barrier and generated 
cerebral edema. Brain ischemia and reperfusion engage 
multiple fatal terminal pathways involving loss of 
membrane integrity in partitioning ions, progressive 
proteolysis, and inability to check these processes 
because of loss of general translation competence and 
reduced survival signal-transduction. Brain tissue is not 
well equipped with anti-oxidant defenses, so reactive 
oxygen species and other free radicals/oxidants, 
released by inflammatory cells, threaten tissue viability 
in the vicinity of the ischemic core (Block, 1999). 
Blood-brain barrier integrity protects the neuronal 
micro-environment. When this barrier integrity is lost, 
inflammatory cells and fluid penetrate the brain, 
causing edema and cell death. Impermeability of the 
blood-brain barrier is maintained by micro-vascular 
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Figure 6: B-MDA in the ischemic rat groups, intraperitoneally injected with 5 and 15 mg/kg of Kombucha solution; Control group, 
received no Kombucha solution; and the Sham group, with no drug administration. Significance difference is denoted by asterisk 
(a). Data are expressed as mean ± SD  
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Figure 7: P-MDA in the ischemic rat groups, intraperitoneally injected with 5 and 15 mg/kg of Kombucha solution; Control group, 
received no Kombucha solution; and the Sham group, with no drug administration. Significance difference is denoted by asterisk 
(a). Data are expressed as mean ± SD 
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 endothelial cells through their tight junctions and basal 
lamina. During cerebral ischemia, endothelial basal 
lamina dissolution starts as soon as 2 hours after the 
onset of ischemia and continues during reperfusion and 
is rapidly followed by an increase in blood-brain barrier 
permeability (Gasche et al., 2001). Ischemia and 
reperfusion stresses disrupt BBBs and increase cerebral 
vascular permeability, leading to the formation of brain 
edema. 
The main source of free radicals generated during 
ischemia is probably resulted from the mitochondria 
damage and generated inflammatory responses (Kondo 
et al., 1997). The brain is protected against these radicals 
by free radical scavengers such as ascorbate, alpha-
tocopherol as well as anti-oxidant enzymes including 
superoxide dismutase, glutathione peroxidase and 
catalase (Warner and Batinić Haberle, 2004). Although 
the expression of these enzymes is increased during 
ischemia, their capacity is limited to the levels of free 
radicals (Margaill and Lerouet, 2005). Oxidative stress 
can directly damage the membrane phospholipids and 
nucleotides and indirectly does through the mediation 
of cellular cascades. Thus, several studies have focused 
on anti-oxidants for the development of effective agents 
in treatment of stroke and cerebral protection. Anti-
oxidants have been developed in many in vitro and in 
vivo experiments and some of them have been 
investigated in clinical trials (McCarty, 2000). 
Due to oxidative stress and inflammation, the main 
reasons for neuronal damage during ischemia and 
ineffectiveness of chemical drugs in ischemia treatment, 
concrete efforts have been focused on the anti-oxidant 
drugs. 
The natural extracts are able to protect neurons from 
ischemic damage (Massaro et al., 2002). The efficiency 
of different natural extracts is depending on their 
bioactive metabolites with anti-oxidant activity, such as 
polyphenols (Carluccio et al., 2003). Polyphenolic 
compounds are able to inhibit endothelial dysfunction 
by reducing the expression of cell adhesion molecules 
(Carluccio et al., 2003), increasing of nitric oxide 
production and scavenging the free radicals in vascular 
endothelium (Moreno, 2003). 
The beneficial effects of Kombucha tea stem from its 
polyphenols, gluconic acid, lactic acid, vitamins, amino 
acids, antibiotics and other nutrients produced during 
the fermentation process (Vijayaraghavan et al., 2000). 
Bhattacharya et al. (2011) showed that Kombucha tea 
possesses more potential effectiveness than black tea to 
ameliorate TBHP-induced oxidative damages and cell 
death in murine hepatocytes. Ibrahim et al. (2013) 
showed the protective effect of Kombucha tea on liver 
Figure 8: Brain histopathological changes in rats after a 60 min ischemia period. Arrows show infarct volume: (a) control group; 
(b) ischemia group 2, intraperitoneally injected with 5 mg/kg Kombucha solution; (c) and ischemia group 3, intraperitoneally 
injected with 15 mg/kg Kombucha solution 
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 and kidney against oxidative stress caused by cadmium 
and gamma radiation. In addition, Gharib (2010) 
showed that Kombucha could improve the damages 
caused by environmental pollutants such as trichloro-
ethylene. 
 
Conclusion 
Kombucha tea has protective effects in ischemia- and 
reperfusion-induced brain damages which my involve 
inhibition of oxidative damage and reduction in 
neuronal cell death. It may be a useful agent for the 
prevention of cerebral damage.  
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